KSS
38
2
AMAT
41
6
BMY
38
-3
PEG
55
2
O
20
-6
TAP
54
-3
NI
67
2
QCOM
56
6
STX
38
4
HIG
50
2
EBAY
39
-3
ES
26
14
VZ
22
-2
NRG
37
5
AVGO
76
2
FDX
33
-11
MCHP
36
3
BBY
46
-2
NOV
47
2
VIX
25
-18
KSS
38
2
AMAT
41
6
BMY
38
-3
PEG
55
2
O
20
-6
TAP
54
-3
NI
67
2
QCOM
56
6
STX
38
4
HIG
50
2
EBAY
39
-3
ES
26
14
VZ
22
-2
NRG
37
5
AVGO
76
2
FDX
33
-11
MCHP
36
3
BBY
46
-2
NOV
47
2
VIX
25
-18
Financhill
Back

Cohen & Steers Real Estate Opportunities and Income Fund Vs. Novo Nordisk AS Industry Stock Comparison

Sell
38

RLTY
Cohen & Steers Real Estate Opportunities and Income Fund

Last Price:
$15.02
Seasonality Move:
-2.75%
Sell
26

NVO
Novo Nordisk AS

Last Price:
$87.33
Seasonality Move:
6.58%
Sell
38
Cohen & Steers Real Estate Opportunities and Income Fund (RLTY) is a Sell

Is Cohen & Steers Real Estate Opportunities and Income Fund a Buy, Sell or Hold?

  • The current Cohen & Steers Real Estate Opportunities and Income Fund [RLTY] share price is $14.80. The Score for RLTY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RLTY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $88.71. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RLTY Stock Price Chart

What is Cohen & Steers Real Estate Opportunities and Income Fund's stock price today?

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $88.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

RLTY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 29.46 Sell
Chaikin Money Flow: 10409 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.27 - 16.31) Sell
Bollinger Bands (100): (15.51 - 16.91) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.52 Sell
Relative Strength Index (14 RSI): 27.28 Sell
Chaikin Money Flow: 14079249 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.16 - 111.42) Sell
Bollinger Bands (100): (106.53 - 131.27) Sell

RLTY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.14 Sell
20-day SMA: 15.73 Sell
50-day SMA: 16.11 Sell
200-day SMA: 15.17 Sell
8-day EMA: 15.1 Sell
20-day EMA: 15.52 Sell
50-day EMA: 15.9 Sell
200-day EMA: 15.4 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.84 Sell
20-day SMA: 105.84 Sell
50-day SMA: 108.65 Sell
200-day SMA: 126.03 Sell
8-day EMA: 99.1 Sell
20-day EMA: 103.93 Sell
50-day EMA: 109.19 Sell
200-day EMA: 117.8 Sell

Cohen & Steers Real Estate Opportunities and Income Fund Earnings Growth & RLTY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.

Cohen & Steers Real Estate Opportunities and Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):